Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-21-146771
Filing Date
2021-12-06
Accepted
2021-12-06 16:12:15
Documents
1
Period of Report
2021-12-02

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2134673d1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2134673d1_4seq1.xml 4 3993
  Complete submission text file 0001104659-21-146771.txt   5498
Mailing Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850
Business Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850 240-864-2600
CASI Pharmaceuticals, Inc. (Issuer) CIK: 0000895051 (see all company filings)

EIN.: 581959440 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 200 ROUTE 31 NORTH SUITE 104 FLEMINGTON NJ 08822
Business Address
Zukiwski Alexander A (Reporting) CIK: 0001569782 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-20713 | Film No.: 211473313